The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
CUHK Study: Ketamine Abuse In Young Reduces Bladder Capacity
Researchers have found that the majority of young people with history of ketamine abuse have a reduced bladder capacity of up to 37 percent.
D-Pharm Gets South Korean Approval For Phase III Study Of Neuro Drug
D-Pharm Ltd. announced this week that the KFDA has approved the IND application for the Phase III MACSI study of DP-b99 in Korea.
Australian DSTO Awards US$13.7 Million In Defense R&D Funding
The Australian Defense Science and Technology Organization has announced US$13.7 million in R&D funding for projects involving helicopters, objects in space, sonar analysis, and solar energy.
Lundbeck Launches Antidepressent Lexapro In Japan
Lexapro® - the most prescribed branded antidepressant in the world - has been launched in Japan by H. Lundbeck A/S and its partners, Mochiba and Mitsubishi Tanabe Pharma.
Australian Project To Highlight 15 Types Of “Forgotten Cancers”
The Forgotten Cancers Project launched yesterday by the Cancer Council Victoria hopes to understand the causes of less common and under-researched cancers.
Academica Sinica Warns Of Academic Brain Drain In Taiwan
Taiwan’s Academia Sinica, along with 18 other key leaders in academia, business, arts, and media sectors have issued a declaration, asking the government to address the brain drain crisis in the country.
WWF, TCM Practitioners Rebut Rhino Horn And Cancer Cure Link
The WWF and TCM experts hope to debunk a myth that rhino horns can be used to treat many disorders such as typhoid fever, convulsions, and cancer.
Aventis Pharma Acquires Universal Medicare’s Nutraceuticals In India
Aventis Pharma announced today that it has entered into a definitive agreement to acquire Universal Medicare Private Limited’s nutraceutical formulation business in India.
Study: China’s Narcolepsy Cases Unrelated To H1N1 Vaccine
New research shows that the occurrence of narcolepsy in China peaks in April, five to seven months after the peak flu season, but the flu vaccine is unlikely the cause of the increase.